Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

47 trials with published results (34%)

Research Maturity

104 completed trials (75% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

2.9%

4 terminated out of 138 trials

Success Rate

96.3%

+9.8% vs benchmark

Late-Stage Pipeline

18%

25 trials in Phase 3/4

Results Transparency

45%

47 of 104 completed with results

Key Signals

47 with results96% success

Data Visualizations

Phase Distribution

117Total
Not Applicable (57)
P 1 (10)
P 2 (25)
P 3 (15)
P 4 (10)

Trial Status

Completed104
Unknown16
Withdrawn6
Terminated4
Not Yet Recruiting3
Recruiting3

Trial Success Rate

96.3%

Benchmark: 86.5%

Based on 104 completed trials

Clinical Trials (138)

Showing 20 of 20 trials
NCT03066219Phase 2CompletedPrimary

Safety and Efficacy of BRM421 for Dry Eye Syndrome

NCT04343287Phase 2CompletedPrimary

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

NCT04198740RecruitingPrimary

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

NCT06977724Phase 1RecruitingPrimary

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)

NCT06190028Not ApplicableTerminatedPrimary

Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy

NCT06375499Not ApplicableCompletedPrimary

Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

NCT07295691Not ApplicableRecruiting

Autologous Serum Eye Drops in Dry Eye Syndrome

NCT01013077Not ApplicableCompletedPrimary

The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability

NCT04030962Phase 1Completed

A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease

NCT06914232Not ApplicableActive Not RecruitingPrimary

Efficacy of Warm Compress Therapy in Enhancing Tear Film Quality and Reducing Postoperative DES

NCT06913556Not ApplicableActive Not RecruitingPrimary

Comparing Effect of Hylorunic Acid and Lipid-coated Carbomer Gel on Dry Eyes After Phacoemulsification in DP

NCT06732830Not ApplicableCompletedPrimary

Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic Drop

NCT06240364Not ApplicableNot Yet RecruitingPrimary

Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome

NCT02510235Not ApplicableCompletedPrimary

Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye

NCT03404115Phase 2CompletedPrimary

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

NCT02507934Not ApplicableCompletedPrimary

Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye

NCT05878067Phase 3CompletedPrimary

A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants

NCT06475027Not Yet RecruitingPrimary

Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome

NCT02101281Phase 2CompletedPrimary

Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye

NCT03982368Phase 2CompletedPrimary

A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye

Scroll to load more

Research Network

Activity Timeline